Mayank Mamtani

Jun 10, 2026

Mayank Mamtani rated AAPG as Buy on Jun 10, 2026, setting a price target of 45. Shares have remained stable near 17.342, leaving the 45 target still in play.

Jun 10, 2026

On Jun 10, 2026, ELTX was given a Buy rating by Mayank Mamtani, with a target price of 27. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

Apr 10, 2026

MGNX received a Buy rating from Mayank Mamtani on Apr 10, 2026, aiming for 9. Momentum has favored the Buy call, with shares climbing from 3.87 to 3.87, rewarding those who trusted the recommendation.

Apr 07, 2026

Mayank Mamtani on Apr 07, 2026 assigned HROW a Buy rating, with a price target of 65. The recommendation remains pending validation as shares consolidate around 35.9.

Mar 25, 2026

On Mar 25, 2026, Mayank Mamtani reaffirmed LCTX with a Buy rating, targeting 4. Shares slid 20.65% despite the recommendation, highlighting downside risks.

Mar 24, 2026

CLYM was rated Buy by Mayank Mamtani on Mar 24, 2026, with a price objective of 26. A bullish response from the market helped close the gap of 15.20 to the target.

Mar 18, 2026

On Mar 18, 2026, Mayank Mamtani initiated coverage on ARCT with a Buy rating and target of 22. The stock’s climb of 5.19% since the call highlights the foresight in the rating.

Feb 23, 2026

Mayank Mamtani issued a Buy recommendation for NKTR on Feb 23, 2026, price target set at 150. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Jan 21, 2026

On Jan 21, 2026, CYTK was evaluated by Mayank Mamtani, who gave a Buy rating and target of 108. This case illustrates how a timely bullish rating can translate into tangible gains of 6.39%.

Dec 10, 2025

Mayank Mamtani rated IRD as Buy on Dec 10, 2025, setting a price target of 9. The call has proven timely, with shares rising 55.60% toward the price target of 9.

Dec 01, 2025

On Dec 01, 2025, CNTA was given a Buy rating by Mayank Mamtani, with a target price of 42. The stock rallied 39.41% after the rating, narrowing the gap to the target of 42 and validating the bullish stance.

Nov 21, 2025

ZYME received a Buy rating from Mayank Mamtani on Nov 21, 2025, aiming for 40. Price action was muted, as shares hovered around 22.85 despite the bullish outlook.

Nov 19, 2025

On Nov 19, 2025, Mayank Mamtani published a Buy outlook on NUVB, with a target of 12. Market action contradicted the Buy thesis, as shares slipped to 4.58.

Nov 10, 2025

Mayank Mamtani on Nov 10, 2025 assigned NVAX a Buy rating, with a price target of 16. The Buy call aligned well with market performance, producing a gain of 20.39%.

Sep 29, 2025

On Sep 29, 2025, Mayank Mamtani reaffirmed MDGL with a Buy rating, targeting 560. The recommendation was supported by strong follow-through as the stock rose from 471.32 to 471.32.

Sep 17, 2025

TGTX was rated Buy by Mayank Mamtani on Sep 17, 2025, with a price objective of 55. A bullish response from the market helped close the gap of 8.38 to the target.

Aug 26, 2025

On Aug 26, 2025, Mayank Mamtani initiated coverage on ACTU with a Buy rating and target of 20. The Buy call has yet to be validated as shares remain 18.05 away from the target.

Aug 13, 2025

Mayank Mamtani issued a Buy recommendation for ALT on Aug 13, 2025, price target set at 18. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Jun 16, 2025

On Jun 16, 2025, MNOV was evaluated by Mayank Mamtani, who gave a Buy rating and target of 5. So far, the Buy call awaits clearer momentum, with shares flat at 1.27.

Mar 27, 2025

Mayank Mamtani rated VXRT as Buy on Mar 27, 2025, setting a price target of 2. The call has proven timely, with shares rising 31.29% toward the price target of 2.

Mar 19, 2025

On Mar 19, 2025, TRVI was given a Buy rating by Mayank Mamtani, with a target price of 20. The stock rallied 96.77% after the rating, narrowing the gap to the target of 20 and validating the bullish stance.

Mar 05, 2025

DNLI received a Buy rating from Mayank Mamtani on Mar 05, 2025, aiming for 35. Momentum has favored the Buy call, with shares climbing from 20.61 to 20.61, rewarding those who trusted the recommendation.

Feb 14, 2025

On Feb 14, 2025, Mayank Mamtani published a Buy outlook on ARWR, with a target of 38. Shares gained 254.54%, underscoring the accuracy of the bullish outlook toward 38.

Feb 07, 2025

Mayank Mamtani on Feb 07, 2025 assigned VKTX a Buy rating, with a price target of 96. The call has struggled to gain traction, with shares losing 14.77%.

Dec 19, 2024

On Dec 19, 2024, Mayank Mamtani reaffirmed CGTX with a Buy rating, targeting 1.5. The recommendation was supported by strong follow-through as the stock rose from 1.14 to 1.14.